GSK:NYSE
GlaxoSmithKline
46,92 USD
arrow_upward
+0,90%(+0,42) 1 d.
46,92 USD
0,00% (0,00)
bedtimePo uzavretí
Zavreté: 12. 10., 16:00:02 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre GSK…
Otvoriť
46,70 USD
Vysoká
47,08 USD
Nízka
46,31 USD
Trh. kap.
94,47 mld.
Priem. obj.
3,91 mil.
Objem
10,35 mil.
Dividenda
3,87 %
Štvrťročná dividenda
0,45 USD
Prvý obchodný deň po vyplatení dividendy
13. 8. 2026
Pomer cena/zárobky
15,03
Max. za 52 týž.
61,70 USD
Min. za 52 týž.
42,84 USD
Výnosy na akciu
3,12 USD
Beta
0,25
Akcie v obehu
2,16 mld.
Počet zamestnancov
67 tis.
Otvoriť
46,70 USD
Vysoká
47,08 USD
Nízka
46,31 USD
Trh. kap.
94,47 mld.
Priem. obj.
3,91 mil.
Objem
10,35 mil.
Dividenda
3,87 %
Štvrťročná dividenda
0,45 USD
Prvý obchodný deň po vyplatení dividendy
13. 8. 2026
Pomer cena/zárobky
15,03
Max. za 52 týž.
61,70 USD
Min. za 52 týž.
42,84 USD
Výnosy na akciu
3,12 USD
Beta
0,25
Akcie v obehu
2,16 mld.
Počet zamestnancov
67 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Patch
·
pred 5 hodinami
Pharma Giant GSK To Expand In Upper Merion, Investing $800 Million
Zacks
·
pred 7 hodinami
Is the Options Market Predicting a Spike in GSK Plc Stock?
TipRanks
·
pred 7 hodinami
GSK Executives Reinvest Dividends in Routine Share Acquisitions
The Pharma Letter
·
pred 11 hodinami
Over $800 million investment from GSK to expand operations in Pennsylvania
Profil
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
Informácie o subjekte GlaxoSmithKline
Generálny riaditeľEmma Walmsley | Emma Walmsley
Zamestnanci66,8 tis.
Dátum založenia27. 12. 2000
Hlavné sídlo-
Odvetvie-
Webgsk.com